Arkolith/Insider Trading/VOR/Form 4

Ra Capital Management, L.P.

Director, 10% OwnerVor Biopharma Inc. (VOR) · full profile →Form 4 · filed Sep 22, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 18, 2025Grant(A)10.0M$5.00$50.0M10.0M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-25-000227) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML